May 25, 2022
According to the research report titled ‘Asia Pacific Joint Reconstruction Devices Market Forecast 2027 By Joint Type, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with MarketStudyReport, Asia Pacific joint reconstruction devices market is expected to exceed a valuation of USD 5.8 billion by 2027.
Surging demand for hip and knee surgeries & ankle joint procedures, rising frequency of arthropathies and fractures among elderly population, increasing incidence of accidents, traumatic events, & sports injuries, are the key factors driving the growth of the Asia Pacific joint reconstruction devices market.
Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4485030/
Additional factors such as high rate of infection leading to revision surgeries, and rapidly growing geriatric population are also stimulating the overall industry outlook.
This research report specializes in offering detailed insights regarding the major development trends, bottlenecks, and other expansion avenues that are impacting the growth pattern of this business space over the study duration. The document also highlights the various market segmentations to understand the various revenue-generating opportunities prevailing in this business domain.
Based on joint type, the knee replacement segment accounted for 50% of market share in 2020, is anticipated to grow exponentially over the forecast period, owing to surging prevalence of osteoporosis, osteoarthritis, and other orthopedic conditions.
Regionally, Japan generated revenues worth USD 850 million for Asia-Pacific join reconstruction devices industry in 2020, on account of the growing disease prone population, ability of the product to augment life expectancy, and promising potential of implants.
Leading companies operating in Asia Pacific joint reconstruction device market are Zimmer Biomet, Stryker Corporation, Medtronic plc, Medacta Corporation, NuVasive Inc., Globus Medical, Inc., Waldemar Link GmbH & Co. KG, and Conformis Inc.
These companies are focusing on research & development activities as well as technological innovations to acquire a competitive advantage in this industry landscape.